| |
| Corporate advisory
board |
The role of the Corporate Advisory
Board (CAB) is to advise the TFOS on industry issues,
as well as to help promote the objectives of the TFOS.
To be considered for CAB membership, each company
will be asked for an annual sponsorship. Membership
on the CAB is limited to one individual per company.
The term of the CAB appointment is 3 years and may
be renewable upon recommendation of the Governing
Board and the CAB member's agreement. At present,
the composition of this Board includes the following
companies:
|
|
Alcon
Fort Worth, TX, USA
Dr. Michael Brubaker
Director, R&D Dry Eye |
Allergan
Irvine, CA, USA
Ms. Amy Brill
Global Strategic Marketing, Eye Care Pharmaceuticals
|
AMO
Santa Ana, CA, USA
Mr. Stan Huth
Research Investigator for Eye Care R&D |
Bausch & Lomb
Rochester, NY, USA
Dr. Tim Comstock
Director, Pharmaceutical Clinical Science |
Inspire Pharmaceuticals
Durham, NC, USA
Dr. Benjamin R. Yerxa Chief Scientific Officer, Executive V.P. Strategic Operations
|
Johnson&Johnson
Sherryl Frisch, M.S., M.B.A.
Director, Medical Affairs & Clinical Research
Consumer Eye Care Johnson & Johnson Consumer
& Personal Products Worldwide Division of
Johnson & Johnson Consumer Companies, Inc.
|
Pfizer
La Jolla, CA, USA
Dr. David Eveleth
Worldwide Medical Director of Ophthalmology
|
Santen Pharmaceutical
Osaka, Japan
Dr. Katsuhiko Nakata
General Manager, Research & Development Administration Group
Research & Development Planning & Integration Department |
Sifi S.p.A.
Lavinaio, Italy
Mr. Salvino Benanti
Strategic Planning Manager
Pharma Business Unit |
|
|
Vistakon
Jacksonville, FL, USA
Mr. Frank F. Molock, Jr.
Research Fellow, Research & Development |
|
|
|
|
| Associate
Corporate Sponsors: |
CIBA Vision
(USA)
|
Farmigea
(Italy) |
Senju Pharmaceutical
(Japan) |
|
If your company
is interested in becoming a member of the Corporate
Advisory Board, please contact:
Amy G.
Sullivan
Executive Director
Tear Film & Ocular Surface Society
amy@tearfilm.org
|
|
|
